Rapport Therapeutics, Inc.RAPP
Price (close)
$33.83
Market cap
$1.6B
P/E
—
Revenue (TTM)
—
Net income
-$137.2M
Dividend yield
—
1-year total return
35.5%
Net margin
—
Revenue growth
—
Debt / equity
—
What Rapport Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net income | — | -$34.8M | -$78.3M | -$111.5M |
| Free cash flow | — | -$28.8M | -$67.2M | -$88.1M |
More on RAPP.
- Rapport Therapeutics, Inc. summary
- Rapport Therapeutics, Inc. financial statements
- Rapport Therapeutics, Inc. key metrics
- Rapport Therapeutics, Inc. health scores and style box
- Rapport Therapeutics, Inc. earnings
- Rapport Therapeutics, Inc. dividends
- Rapport Therapeutics, Inc. valuation
- Rapport Therapeutics, Inc. ownership and insiders
- Rapport Therapeutics, Inc. peers
Figures from Rapport Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.